Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Immunomic Therapeutics
1214 Research Blvd, Suite 201
Hershey, PA 17036
Phone: 717-327-1919
http://immunomix.com/

Immunomic Therapeutics (ITI) is a clinical stage biotechnology company that is developing next generation vaccines based on the patented Lysosomal Associated Membrane Protein, or LAMP, Technology. The vaccine platform significantly increases the effectiveness of the immune response to nucleic acid vaccines while simplifying overall vaccine design and delivery, yielding safer, more cost-effective human and animal therapies.

Key Contact
NameTitleE-Mail
Bill HearlCEObillhearl@immunomix.com


Funding Events
DateAmountTypeInvestors
10/17/13$3,000,000 Mid Atlantic Bio Angels
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.